Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

T-Mobile stock bucks a softer market today — what’s driving TMUS as year-end trade thins

T-Mobile stock bucks a softer market today — what’s driving TMUS as year-end trade thins

NEW YORK, December 29, 2025, 14:48 ET — Regular session T-Mobile US shares rose 1.4% on Monday afternoon, outperforming a weaker U.S. market. The stock was up $2.83 at $203.83. The move matters now because Wall Street is in the final, holiday-thinned stretch of the year, when smaller flows can move prices more than usual. Investors are also recalibrating around the path of interest rates after the Federal Reserve’s late-2025 easing. Reuters U.S. Treasury yields edged lower as investors adjusted their bets for more Fed rate cuts next year, Reuters reported. Lower yields can support telecom stocks that trade as
Marvell stock falls today: MRVL tracks tech pullback as traders eye Fed minutes

Marvell stock falls today: MRVL tracks tech pullback as traders eye Fed minutes

NEW YORK, December 29, 2025, 14:44 ET — Regular session Marvell Technology, Inc. shares fell about 1.1% to $85.41 in afternoon trading on Monday, tracking a broader retreat in technology stocks at the start of the final week of the year. The Nasdaq-listed chipmaker has traded between $84.21 and $86.09 so far in the session. The move matters because Marvell is closely tied to data-center spending, where investor sentiment can swing quickly on any shift in views about the pace of AI infrastructure buildouts. With liquidity typically thinner late in December, sector moves can translate into sharper single-stock swings. Wall
Carvana slips in thin year-end trade as Wall Street pares risk

Carvana slips in thin year-end trade as Wall Street pares risk

NEW YORK, December 29, 2025, 13:51 ET — Regular session Shares of Carvana Co. (CVNA) were down about 0.6% at $436.00 in afternoon trading on Monday, giving back early gains in a quiet, year-end market. The pullback comes after a bruising run in 2025. Carvana has returned about 116% year-to-date on a total-return basis, according to Total Real Returns, leaving the stock sensitive to small shifts in risk appetite. That sensitivity is in focus as the market heads into the final trading days of the year. Many money managers rebalance portfolios in late December, and high-momentum names can swing sharply
JNJ stock edges higher after Johnson & Johnson closes $3.05B Halda deal; earnings outlook next

JNJ stock edges higher after Johnson & Johnson closes $3.05B Halda deal; earnings outlook next

NEW YORK, December 29, 2025, 14:38 ET — Regular session Johnson & Johnson shares were up about 0.3% at $208.28 in afternoon trading on Monday after the healthcare conglomerate said it had completed its $3.05 billion cash acquisition of Halda Therapeutics. JNJ.com The close matters because it brings Johnson & Johnson a clinical-stage oncology platform and assets as investors press large drugmakers to keep replenishing their pipelines ahead of patent expirations and pricing pressure. It also puts the focus back on execution: the deal is expected to dent near-term profit metrics, and Johnson & Johnson has flagged its next earnings
Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears

Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears

NEW YORK, December 29, 2025, 14:15 ET — Regular session Bristol Myers Squibb shares fell on Monday, with the drugmaker lagging a slightly weaker U.S. stock market in holiday-thinned trading. The stock was down 0.7% at $54.27 in afternoon trade. The move matters now because the final week of the year often brings abrupt swings on light volume, even when company-specific headlines are scarce. Bristol Myers is also approaching two calendar catalysts that can influence positioning: its next dividend record date and its next earnings report. U.S. stocks eased from record highs at the start of a holiday-shortened week, and
NBIS stock slides after Nebius CEO files to sell shares as AI trade cools

NBIS stock slides after Nebius CEO files to sell shares as AI trade cools

NEW YORK, December 29, 2025, 14:07 ET — Regular session Nebius Group N.V. shares fell on Monday after a filing showed founder and CEO Arkady Volozh intends to sell a small portion of his stake. The timing matters because NBIS has become a high-volatility proxy for investor appetite for AI data-center capacity, and year-end trading can amplify price swings. Google Finance data shows the stock has ranged from about $18 to $141 over the past 52 weeks, with a market value around $21.7 billion. Google The broader AI trade also cooled. Wall Street’s main indexes opened the final trading week
Uber stock steadies in late-2025 market wobble as traders watch the next catalyst

Uber stock steadies in late-2025 market wobble as traders watch the next catalyst

NEW YORK, December 29, 2025, 14:09 ET — Regular session. Uber Technologies Inc. shares edged up 0.1% to $81.38 in afternoon trading on Monday, bucking a softer tape in the final week of the year. The stock traded between $80.61 and $82.19. The muted move matters now because liquidity is thin and many investors are rebalancing into year-end, making single-stock moves more sensitive to macro swings and sector rotation. For Uber, that backdrop comes as traders look for clarity on holiday-quarter demand and the legal headlines hanging over its subscription business. On Wall Street, the S&P 500 and Nasdaq were
Pfizer stock today: PFE edges down as Wall Street looks to Feb. 3 results update

Pfizer stock today: PFE edges down as Wall Street looks to Feb. 3 results update

NEW YORK, December 29, 2025, 2:08 PM ET — Regular session Pfizer shares dipped slightly on Monday, trading down about 0.1% at $25.06 as of 2:08 p.m. ET. The stock has moved between $24.99 and $25.19 in the regular session. The muted move matters because liquidity is thinning into year-end, leaving defensive names like large drugmakers more sensitive to sector headlines and positioning. Reuters reported trading volumes were expected to be light this week, with U.S. markets shut on Thursday for New Year’s Day. Reuters For Pfizer, the backdrop is still its long-dated reset story: investors are weighing whether its
CrowdStrike stock dips as year-end tech pullback drags cybersecurity names

CrowdStrike stock dips as year-end tech pullback drags cybersecurity names

NEW YORK, December 29, 2025, 13:49 ET — Regular session. CrowdStrike Holdings, Inc. shares fell about 1% on Monday, down $4.77 to $476.42 in afternoon trading. The move put the cybersecurity firm among the decliners as investors pared exposure to technology shares in the final trading week of 2025 after last week’s rally pushed U.S. indexes to record highs, a Reuters report showed. Reuters Trading is expected to stay thin in the holiday-affected week, with U.S. markets closed on Thursday for New Year’s Day. Minutes from the Federal Reserve’s previous meeting and a weekly reading of jobless claims are among
Oklo stock falls today as mini nuclear reactor names slide — what’s driving OKLO now

Oklo stock falls today as mini nuclear reactor names slide — what’s driving OKLO now

NEW YORK, December 29, 2025, 14:04 ET — Regular session Oklo Inc. shares fell 3.5% to $74.24 in afternoon trading on Monday, underperforming a modestly weaker U.S. market. The stock traded between $73.90 and $78.48, with about 5.4 million shares changing hands. The decline followed a broader pullback in U.S.-listed small modular reactor stocks after a Financial Times column flagged fresh doubts about SMR economics and deployment timelines. Financial Times Small modular reactors, or SMRs, are smaller nuclear units pitched as easier to manufacture and assemble than traditional large plants. The group has become a crowded “AI power” trade as
Texas Instruments stock dips as Weebit Nano ReRAM license lands — what TXN investors watch next

Texas Instruments stock dips as Weebit Nano ReRAM license lands — what TXN investors watch next

NEW YORK, December 29, 2025, 13:55 ET — Regular session Texas Instruments shares fell 0.8% to $175.49 in afternoon trading on Monday after Weebit Nano said it licensed its resistive random access memory (ReRAM), a type of non-volatile memory that retains data without power, to the chipmaker. “We are excited to collaborate with Weebit Nano to integrate ReRAM memory technology into our process technologies and products,” Amichai Ron, senior vice president of TI Embedded Processing, said. Weebit The deal matters because chipmakers are looking for alternatives to embedded flash memory as they pack more features into smaller chip designs and
AI stocks slide today as Nvidia drops after Intel confirms $5 billion stake sale

AI stocks slide today as Nvidia drops after Intel confirms $5 billion stake sale

NEW YORK, December 29, 2025, 14:06 ET — Regular session Artificial intelligence (AI) stocks slipped on Monday afternoon, with Nvidia down about 1.7% after Intel said it had completed a $5 billion private share sale to the chip designer. Intel The move matters now because a small group of AI-heavyweights has driven much of the market’s momentum, leaving investors quick to adjust risk when the leaders wobble. Trading has also turned thin in the holiday week, a setup that can exaggerate swings when big funds rebalance portfolios into year-end, Reuters reported. Reuters In a Form 8-K, Intel said it issued

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop